HEPATIC INSUFFICIENCY
Clinical trials for HEPATIC INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC INSUFFICIENCY trials appear
Sign up with your email to follow new studies for HEPATIC INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doctors search for better way to spot deadly immune storm in ICU
Diagnosis Recruiting nowThis study aims to see how well a diagnostic scoring system, called the HScore, works for identifying a dangerous immune system overreaction (HLH) in critically ill patients. It will look back at the medical records of 100 adult patients with liver problems who were treated in an…
Matched conditions: HEPATIC INSUFFICIENCY
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC
-
First human test: how does a new drug act in damaged livers?
Knowledge-focused Recruiting nowThis is an early safety study to see how a new drug, eloralintide, is processed by the body in people with healthy livers and in people with mild, moderate, or severe liver damage. Researchers will give a single injection and then closely monitor participants for about 14 weeks t…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
First human test: how does a bad liver handle a new drug?
Knowledge-focused Recruiting nowThis is an early safety study to understand how a new drug, LY3537031, is processed by the body in people with different levels of liver function. It will enroll 32 people, including healthy volunteers and those with mild, moderate, or severe liver impairment. The main goal is to…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test new Drug's safety in people with liver issues
Knowledge-focused Recruiting nowThis study aims to understand how different levels of liver problems affect how the body processes a new medicine called BI 1584862. It involves adults with mild, moderate, or severe liver impairment, as well as healthy matched participants for comparison. Each participant receiv…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC